Authors: Lord, Christopher J, Ashworth, Alan
Superior Title: Science, vol 355, iss 6330
Subject Terms: Genetics, Cancer, 5.1 Pharmaceuticals, 5.2 Cellular and gene therapies, Development of treatments and therapeutic interventions, Good Health and Well Being, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Protocols, BRCA2 Protein, Clinical Trials as Topic, DNA Damage, DNA Repair, Germ-Line Mutation, Humans, Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Synthetic Lethal Mutations, Ubiquitin-Protein Ligases, General Science & Technology
Time: 1152 - 1158
File Description: application/pdf
Relation: qt00x5r9k4; https://escholarship.org/uc/item/00x5r9k4
Availability: https://escholarship.org/uc/item/00x5r9k4
Authors: Lord, Christopher J.1, Ashworth, Alan1
Superior Title: Nature. 1/19/2012, Vol. 481 Issue 7381, p287-294. 8p. 2 Diagrams, 1 Chart.
Subject Terms: *DNA damage, *CANCER treatment, *GENOMICS, *DNA repair, *PHENOTYPES, *NUCLEOTIDE sequence
Authors: Brough, Rachel, Bajrami, Ilirjana, Vatcheva, Radost, Natrajan, Rachael, Reis-Filho, Jorge S, Lord, Christopher J, Ashworth, Alan
Superior Title: EMBO Journal; 3/7/2012, Vol. 31 Issue 5, p1160-1176, 17p, 1 Color Photograph, 1 Diagram, 1 Chart, 5 Graphs
Subject Terms: BRCA proteins, CELL cycle, BREAST cancer treatment, CANCER chemotherapy, GENOMES, HEALTH outcome assessment, DNA damage
Authors: Lord, Christopher J., McDonald, Sarah, Swift, Sally1, Turner, Nicholas C.1, Ashworth, Alan Alan.Ashworth@icr.ac.uk
Superior Title: DNA Repair. Dec2008, Vol. 7 Issue 12, p2010-2019. 10p.
Subject Terms: *DNA repair, *POLY(ADP-ribose) polymerase, *CANCER treatment, *BREAST cancer research, *DNA damage, *GENETIC testing, *CLINICAL trials, *GENETICS
Authors: Edwards, Stacey L., Brough, Rachel, Lord, Christopher J., Natrajan, Rachael, Vatcheva, Radost, Levine, Douglas A., Boyd, Jeff, Reis-Filho, Jorge S., Ashworth, Alan
Superior Title: Nature; 2/28/2008, Vol. 451 Issue 7182, p1111-1115, 5p, 1 Diagram, 2 Charts, 3 Graphs
Subject Terms: GENETIC mutation, THERAPEUTICS, DNA damage, GENETIC recombination, HOMOLOGY (Biology), DRUG resistance, GENOMICS, CELLS, EXPERIMENTAL design
Authors: Martin, Sarah A1, Lord, Christopher J1, Ashworth, Alan1 Alan.Ashworth@icr.ac.uk
Superior Title: Current Opinion in Genetics & Development. Feb2008, Vol. 18 Issue 1, p80-86. 7p.
Subject Terms: *DNA repair, *CANCER treatment, *ANTINEOPLASTIC agents, *DNA damage, *CANCER cells
Authors: Arias-Lopez, Carmen, Lazaro-Trueba, Iciar, Kerr, Peter, Lord, Christopher J., Dexter, Tim, Iravani, Marjan, Ashworth, Alan, Silva, Augusto
Superior Title: EMBO Reports; Feb2006, Vol. 7 Issue 2, p219-224, 6p, 1 Diagram, 3 Graphs
Subject Terms: GENOMES, HOMOLOGY (Biology), DNA repair, DNA damage, GENETIC mutation, MESSENGER RNA, GENES
Authors: Farmer, Hannah, McCabe, Nuala, Lord, Christopher J., Tutt, Andrew N. J., Johnson, Damian A., Richardson, Tobias B., Santarosa, Manuela, Dillon, Krystyna J., Hickson, Ian, Knights, Charlotte, Martin, Niall M. B., Jackson, Stephen P., Smith, Graeme C. M., Ashworth, Alan
Superior Title: Nature; 4/14/2005, Vol. 434 Issue 7035, p917-921, 5p
Subject Terms: DNA repair, DNA damage, BIOCHEMICAL genetics, GENETIC mutation, CANCER genetics, APOPTOSIS
Authors: Zelceski, A, Francica, P, Lingg, L, Mutlu, M, Stok, C, Liptay, M, Alexander, J, Baxter, JS, Brough, R, Gulati, A, Haider, S, Raghunandan, M, Song, F, Sridhar, S, Forment, JV, O'Connor, MJ, Davies, BR, van Vugt, MATM, Krastev, DB, Pettitt, SJ, Tutt, ANJ, Rottenberg, S, Lord, CJ
Contributors: Song, Feifei, Lord, Christopher
Subject Terms: CP: Molecular biology, DNA repair, MND1, PARP inhibitor, PSMC3IP, PSMC3IP and PARPi sensitivity, Poly(ADP-ribose) Polymerase Inhibitors, Antineoplastic Agents, DNA Damage, BRCA1 Protein, Recombinational DNA Repair, Cell Line, Tumor
Subject Geographic: United States
File Description: Print-Electronic; application/pdf
Relation: ARTN 112484; S2211-1247(23)00495-3; Cell Reports, 2023, 42 (5), pp. 112484 -; https://repository.icr.ac.uk/handle/internal/5918
Authors: Zatreanu, D, Robinson, HMR, Alkhatib, O, Boursier, M, Finch, H, Geo, L, Grande, D, Grinkevich, V, Heald, RA, Langdon, S, Majithiya, J, McWhirter, C, Martin, NMB, Moore, S, Neves, J, Rajendra, E, Ranzani, M, Schaedler, T, Stockley, M, Wiggins, K, Brough, R, Sridhar, S, Gulati, A, Shao, N, Badder, LM, Novo, D, Knight, EG, Marlow, R, Haider, S, Callen, E, Hewitt, G, Schimmel, J, Prevo, R, Alli, C, Ferdinand, A, Bell, C, Blencowe, P, Bot, C, Calder, M, Charles, M, Curry, J, Ekwuru, T, Ewings, K, Krajewski, W, MacDonald, E, McCarron, H, Pang, L, Pedder, C, Rigoreau, L, Swarbrick, M
Contributors: Haider, Syed, Pettitt, Stephen, Lord, Christopher
Subject Terms: Organoids, Cell Line, Tumor, Animals, Humans, Mice, Rats, Ovarian Neoplasms, DNA Damage, Deoxyribonucleases, DNA-Directed DNA Polymerase, Cell Cycle Proteins, DNA-Binding Proteins, BRCA1 Protein, BRCA2 Protein, Nucleic Acid Synthesis Inhibitors, Drug Screening Assays, Antitumor, Inhibitory Concentration 50, Apoptosis, Cell Proliferation, Cell Survival, DNA Repair, Allosteric Regulation, Drug Resistance, Neoplasm, Female, Homologous Recombination, Poly(ADP-ribose) Polymerase Inhibitors, Tumor Suppressor p53-Binding Protein 1
File Description: Electronic; ?; application/pdf
Relation: Nature communications, 2021, 12 (1), pp. 3636 - ?; https://repository.icr.ac.uk/handle/internal/4762
Authors: Holme, H, Gulati, A, Brough, R, Fleuren, EDG, Bajrami, I, Campbell, J, Chong, IY, Costa-Cabral, S, Elliott, R, Fenton, T, Frankum, J, Jones, SE, Menon, M, Miller, R, Pemberton, HN, Postel-Vinay, S, Rafiq, R, Selfe, JL, von Kriegsheim, A, Munoz, AG, Rodriguez, J, Shipley, J, van der Graaf, WTA, Williamson, CT, Ryan, CJ, Pettitt, S, Ashworth, A, Strauss, SJ, Lord, CJ
Contributors: Campbell, James, Chong, Yu-Shing, Jones, Samuel, Selfe, Joanna, Shipley, Janet, Pettitt, Stephen, Lord, Christopher
Subject Terms: Cell Line, Tumor, Cell Nucleus, Humans, Osteosarcoma, DNA Damage, BRCA1 Protein, BRCA2 Protein, Drug Screening Assays, Antitumor, DNA Repair, Mutagenesis, Drug Resistance, Neoplasm, Mutation, Rad51 Recombinase, High-Throughput Screening Assays, CRISPR-Cas Systems, Datasets as Topic, Poly(ADP-ribose) Polymerase Inhibitors
File Description: Electronic; ?; application/pdf
Relation: Scientific reports, 2018, 8 (1), pp. 10614 - ?; https://repository.icr.ac.uk/handle/internal/2226
Authors: Naidoo, K, Wai, PT, Maguire, SL, Daley, F, Haider, S, Kriplani, D, Campbell, J, Mirza, H, Grigoriadis, A, Tutt, A, Moseley, PM, Abdel-Fatah, TMA, Chan, SYT, Madhusudan, S, Rhaka, EA, Ellis, IO, Lord, CJ, Yuan, Y, Green, AR, Natrajan, R
Contributors: Haider, Syed, Naidoo, Kalnisha, Natrajan, Rachael, Tutt, Andrew, Lord, Christopher, Campbell, James, Yuan, Yinyin
Subject Terms: Humans, Breast Neoplasms, DNA Damage, Cyclin-Dependent Kinases, Immunohistochemistry, Retrospective Studies, Middle Aged, Female, Biomarkers, Tumor
File Description: Print-Electronic; 315; application/pdf
Relation: Molecular cancer therapeutics, 2018, 17 (1), pp. 306 - 315; https://repository.icr.ac.uk/handle/internal/849
Authors: Nikkilä, J, Kumar, R, Campbell, J, Brandsma, I, Pemberton, HN, Wallberg, F, Nagy, K, Scheer, I, Vertessy, BG, Serebrenik, AA, Monni, V, Harris, RS, Pettitt, SJ, Ashworth, A, Lord, CJ
Contributors: Campbell, James, Lord, Christopher, Pettitt, Stephen
Subject Terms: Cell Line, Humans, DNA Damage, Cisplatin, Uracil, Cytidine Deaminase, Cell Cycle Proteins, Nuclear Proteins, Minor Histocompatibility Antigens, Blotting, Western, Gene Expression Regulation, Neoplastic, RNA Interference, Mutation, Tumor Suppressor Protein p53, Protein-Tyrosine Kinases, Gene Knockout Techniques, HEK293 Cells, Cell Cycle Checkpoints, G2 Phase Cell Cycle Checkpoints, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2, CRISPR-Cas Systems, Poly(ADP-ribose) Polymerase Inhibitors, Checkpoint Kinase 1
File Description: Print-Electronic; 123; application/pdf
Relation: British journal of cancer, 2017, 117 (1), pp. 113 - 123; https://repository.icr.ac.uk/handle/internal/850
Authors: Rouleau-Turcotte, Élise1 (AUTHOR), Krastev, Dragomir B.2 (AUTHOR), Pettitt, Stephen J.2 (AUTHOR), Lord, Christopher J.2 (AUTHOR), Pascal, John M.1 (AUTHOR) john.pascal@umontreal.ca
Superior Title: Molecular Cell. Aug2022, Vol. 82 Issue 16, p2939-2939. 1p.
Subject Terms: *ADP-ribosylation, *POST-translational modification, *CATALYTIC domains, *DNA damage, *POLY(ADP-ribose) polymerase, *NAD (Coenzyme), *CRYSTAL structure
Authors: Neijenhuis, Sari1, Bajrami, Ilirjana1, Miller, Rowan1, Lord, Christopher J.1 Chris.Lord@icr.ac.uk, Ashworth, Alan1 Alan.Ashworth@icr.ac.uk
Superior Title: DNA Repair. Jun2013, Vol. 12 Issue 6, p394-402. 9p.
Subject Terms: *MICRORNA, *POLY ADP ribose, *KILLER cells, *GENETIC regulation, *SENSITIVITY analysis, *DNA damage
Authors: Martin, Sarah A.1,2, McCabe, Nuala1,2, Mullarkey, Michelle3, Cummins, Robert3, Burgess, Darren J.1,2, Nakabeppu, Yusaku4, Oka, Sugako4, Kay, Elaine3, Lord, Christopher J.2 chris.lord@icr.ac.uk, Ashworth, Alan1,2 alan.ashworth@icr.ac.uk
Superior Title: Cancer Cell. Mar2010, Vol. 17 Issue 3, p235-248. 14p.
Subject Terms: *CANCER treatment, *DNA polymerases, *TARGETED drug delivery, *TUMOR suppressor proteins, *MITOCHONDRIAL DNA, *CELL cycle, *DNA damage
Authors: Brough, Rachel1,2, Wei, Debbie3, Leulier, Sophie1,2, Lord, Christopher J.2, Rong, Yikang S.3, Ashworth, Alan1,2 Alan.Ashworth@icr.ac.uk
Superior Title: DNA Repair. Jan2008, Vol. 7 Issue 1, p10-19. 10p.
Subject Terms: *DROSOPHILA melanogaster, *DNA damage, *DNA repair, *DNA, *GENE conversion
Authors: Brandsma, I, Fleuren, EDG, Williamson, CT, Lord, CJ
Contributors: Lord, Christopher
Subject Terms: Animals, Humans, Neoplasms, DNA Damage, Antineoplastic Agents, Protein Kinase Inhibitors, Drug Design, Mutation, Molecular Targeted Therapy, Biomarkers, Poly(ADP-ribose) Polymerase Inhibitors
File Description: Print-Electronic; 1355; application/pdf
Relation: Expert opinion on investigational drugs, 2017, 26 (12), pp. 1341 - 1355; https://repository.icr.ac.uk/handle/internal/1071
Authors: Lord, CJ, Ashworth, A
Contributors: Lord, Christopher
Subject Terms: Humans, Neoplasms, DNA Damage, Ubiquitin-Protein Ligases, BRCA2 Protein, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Protocols, DNA Repair, Germ-Line Mutation, Clinical Trials as Topic, Poly(ADP-ribose) Polymerase Inhibitors, Synthetic Lethal Mutations
File Description: Print-Electronic; 1158; application/pdf
Relation: Science (New York, N.Y.), 2017, 355 (6330), pp. 1152 - 1158; https://repository.icr.ac.uk/handle/internal/543